Memantine Tablets (Memantine Hydrochloride)
Memantine Hydrochloride 10mg
Tablet · Prescription medication
Ilhwa Co., Ltd.
MFDS item code 201906381 · Approved 2019.09.10
This product's status changed to Expired on 2024.09.10. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of moderate to severe Alzheimer's disease
This medication is used to treat patients with moderate to severe Alzheimer's disease.
1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows until the maintenance dose is reached. Week 1 (Days 1–7): Administer 5mg daily for 7 days. Week 2 (Days 8–14): Administer 10mg daily (5mg twice daily) for 7 days. Week 3 (Days 15–21): Administer 15mg daily (10mg in the morning and 5mg in the evening) for 7 days. From Week 4 onward: Administer 20mg daily (10mg twice daily). Maintenance dose: The recommended maintenance dose is 20mg daily (10mg twice daily). 2. Elderly patients: Based on clinical data, the recommended dose for elderly patients aged 65 years or older is 20mg daily (10mg twice daily). 3. Patients with renal impairment: No dose adjustment is needed in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-50 mL/min), the daily dose should be reduced to 10mg. If well tolerated, the dose may be increased to 20mg daily at least 7 days after administration, following the standard dose-escalation regimen. In patients with severe renal impairment (creatinine clearance 5-30 mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment: No dose adjustment is needed in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.
This medication should not be used in patients with known allergies to its components. It is also advisable not to administer it to patients with significantly impaired liver function or severely compromised kidney function. Patients with a history of seizures or convulsions, or those at high risk of seizures, should be particularly cautious when using this medication. Additionally, concomitant use with certain drugs such as amantadine, ketamine, or dextromethorphan may exacerbate side effects and should be avoided. Careful monitoring should be conducted in situations where the acidity of urine may change, such as with rapid dietary changes or specific urinary tract infections. Due to a lack of safety data in patients who recently suffered heart attacks, congestive heart failure, or uncontrolled hypertension, this drug should be administered with caution in these patients. When taking this medication, side effects such as dizziness, headaches, constipation, drowsiness, and hypertension may occur, thus it’s essential to consult a physician if symptoms worsen. Also, rare neurological symptoms such as mental confusion, hallucinations, and seizures may arise, so caution is advised. This drug may interact with other medications, so especially when taken alongside NMDA antagonists, skeletal muscle relaxants, antipsychotics, or anticoagulants, it should only be used under medical guidance. Co-administration with certain drugs may change the concentration of this medication in the blood and increase the risk of side effects. Pregnant women should exercise caution when taking this medication due to the potential risk to the fetus, and it is recommended to discontinue breastfeeding while on this medication. The safety and efficacy of this medication have not been established in children or adolescents under 18 years of age, so its use is not advisable in these populations. In case of overdose, central nervous system symptoms or gastrointestinal symptoms may occur, and immediate medical attention is necessary. No specific antidote is available for overdose, so appropriate treatment is essential for symptomatic management. This medication may affect the speed of reaction and concentration of the patient; therefore, caution is needed when driving or operating machinery. When storing, keep it in a safe place out of reach of children, and it is beneficial to store it in its original packaging to maintain the quality of the medication.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. It is best kept at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the medication's efficacy over time.
White rectangular film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Memantine Hydrochloride 10mg
Tablet · Prescription medication
Ilhwa Co., Ltd.
Memantine Hydrochloride 1g
Solution · Prescription medication
Lundbeck Korea Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Lundbeck Korea Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Ildong Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Unimed Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Myongin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.